FDA clears Oncobionic to market surgical technology

11/28/2006 | Forbes

Oncobionic received clearance from the FDA to market medical device maker AngioDynamics' irreversible electroporation technology for surgeries, AngioDynamics said. AngioDynamics announced its $25 million acquisition of Oncobionic in October.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC